GL1X · GenesisL1 explorer

MolNFT v1 · #69797 · protein

Discovery of (thienopyrimidin-2-YL)AMINOPYRIMIDINES as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3- KINASE/MTOR inhibitors for the treatment of cancer

3L16 · Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic…: “Discovery of (thienopyrimidin-2-YL)AMINOPYRIMIDINES as potent, selective, and orally available pan-PI3-kinase…”. X-ray diffraction, 1 ligand (JZX), 13 pockets (best…

PDB
3L16
Type
protein
Length
841 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153
UniProt
P48736
Ligands
JZX
Pockets
13 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153)protein84143% helix, 16% strandP48736

Ligands and binding sites

  • JZX · 5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyridin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111150.820.8374empty
24890.670.7865empty
33650.660.7935JZX
41220.520.8123empty
52050.520.7732empty

Compared structures

  • 3L16 · Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.